TCS wins the India Pharma Award 2019

Tata Consultancy Services, announced that its cloud-based clinical solutions and services suite, TCS Advanced Drug Development (ADD), has won an award in the category of Excellence in Ancillary Pharma Services, at the lndia Pharma Awards 2019.

The lndia Pharma Awards bring together industry pioneers and recognize outstanding examples of innovation that improve the pharma industry. TCS was recognized for its leadership in leveraging automation, artificial intelligence (Al) and lot through its intellectual property and commercial-off-the-shelf offerings, to digitize and transform patient engagement, metadata management and regulatory submissions for life sciences organizations.

Debashis Ghosh, Global Head, Life Sciences and Healthcare, TCS, said, “We are building future-proof technology platforms to transform drug development by harnessing our deep knowledge of the life sciences industry, coupled with expertise in digital and At technologies. This award is a testament to the advanced capabilities of our TCS ADD suite that digitally transforms clinical trials and delivers increased speed to market, improved regulatory compliance and enhanced patient experiences.”

TCS ADD is a suite of cloud-based platforms adopted by 18 leading global life sciences companies to transform their product innovation initiatives. lt streamlines the entire clinical R&D value chain, spanning clinical data management, metadata management, pharmacovigilance, patient engagement, clinical operations, and data analytics and insights. The suite fosters optimized study planning, accelerates study setup and execution, manages comprehensive and new data sources, derives meaningful insights, enables adherence to safety and regulatory needs, improves patient engagement, and supports adaptive trials.

The suite is powered by a cognitive engine called ‘Decision Fabric’ that enables the automation of complex business processes. It leverages cloud architecture and intuitive user experience design and aligns to the Good Clinical Practice guidelines and privacy regulations.

What's your take on this post ? Comment: